The purpose of this study is to determine whether the varying lengths of oral contraceptive pills (OCP) have a different effect on lowering testosterone levels in the body, reducing clinical signs of hyperandrogenism, and altering mood symptoms and overall quality of life. Participants are randomized to receive either the traditional cyclical OCP therapy or continuous OCP therapy for 6 months.
You may be eligible if you are: female (or assigned female at birth), aged 15-40, diagnosed with PCOS, and have evidence of either biochemical or clinical evidence of high androgens
Heather Huddleston, MD
Principal Investigator
For more information or additional PCOS related studies, please visit our PCOS clinic website.